Months of Dull Central Wrist Pain: Don’t Mistake Kienböck’s Disease (Lunate Osteonecrosis) for a TFCC Tear or Tenosynovitis — Dr. Moriwaki on How Stem Cell Culture Supernatant Wrist Injection Can Address the Intra-articular Inflammatory Environment2026.07.27

A wrist that has felt heavy and dull for months, with a sharp ache running through the joint every time you twist off a bottle cap or turn a doorknob — one of the wrist disorders most often dismissed as “overuse” or “tenosynovitis” while quietly worsening is Kienböck’s disease, also known as lunate osteonecrosis. The lunate sits at the center of the carpal bones and is intrinsically fed by only one or two thin nutrient arteries. Add repetitive mechanical load, a prior injury, or an anatomical factor such as ulnar minus variance, and the blood supply to the bone can fail, letting osteonecrosis and collapse progress silently over months to years. In this article, Dr. Shin Moriwaki, our supervising physician at AVAN TOKYO Ginza, outlines how to differentiate lunate osteonecrosis from TFCC tears, de Quervain’s tenosynovitis, and midcarpal osteoarthritis, how to read progression via the Lichtman classification, and where stem cell culture supernatant wrist injection can — and cannot — reasonably contribute.

Key Points

・Kienböck’s disease (lunate osteonecrosis) is a wrist disorder in which the centrally located lunate undergoes ischemia, necrosis, and collapse; it affects laborers and women in their 20s to 40s more often than commonly realized.

・Dull pain over the dorsal and volar center of the wrist together with limited dorsiflexion are the main symptoms; failure to differentiate from TFCC tears, de Quervain’s tenosynovitis, and rheumatoid arthritis often delays diagnosis by years.

・The Lichtman classification stages I through IV guides progression assessment; from stage III onward, surgical options such as radial shortening osteotomy or partial wrist arthrodesis enter the discussion.

・The central battleground of lunate osteonecrosis is bone blood supply. Stem cell culture supernatant wrist injection is not a treatment that cures the necrosis itself, but a supportive option that modulates secondary synovitis, cartilage deterioration, and joint pain.

What Is Kienböck’s Disease (Lunate Osteonecrosis)? Ischemic Change in a Small Central Carpal Bone

The lunate sits between the distal radius and the midcarpal joint and serves as the pivot of wrist motion. Because it is often supplied by only one or two slender nutrient arteries, repetitive impact, prior injury, or anatomical factors such as ulnar minus variance (an ulna shorter than the radius) can disrupt its internal blood supply. Once perfusion falls, intraosseous pressure rises, cancellous bone dies, and eventually the bone flattens and collapses, gradually distorting its relationship to the surrounding carpal bones. Because this process unfolds over months to years, patients often continue with “overuse” or “just rest and see” until the wrist has already deformed significantly. Kienböck’s disease can arise in middle-aged men without any obvious fracture history, which distinguishes its clinical course fundamentally from ordinary occupational tenosynovitis or a self-limited sprain.

Don’t Mistake It for a TFCC Tear or Tenosynovitis: Locating the Pain and Provocative Motions

Pain from lunate osteonecrosis concentrates over the dorsal center of the wrist, roughly along the line connecting Lister’s tubercle to the third finger. A TFCC tear, by contrast, is felt on the ulnar (little-finger) side, and de Quervain’s tenosynovitis over the radial (thumb) side; careful palpation can usually distinguish them. Kienböck’s typically produces a sharp central-dorsal pain on forced dorsiflexion or lifting heavy objects, together with reduced grip strength and restricted dorsiflexion. Plain X-rays may look normal in early disease; when suspicion arises, MRI is essential. On T1-weighted MRI, decreased signal in the lunate appears early, allowing diagnosis at Lichtman stage I in many cases. Keep TFCC injury, de Quervain’s tenosynovitis, rheumatoid arthritis, and midcarpal osteoarthritis on the differential list, and do not hesitate to move to imaging when central wrist pain persists.

Reading Progression via the Lichtman Classification and Where Surgery Enters the Discussion

The Lichtman classification is widely used to stage lunate osteonecrosis. Stage I shows no plain-film abnormality but abnormal MRI signal. Stage II shows sclerosis of the lunate with preserved shape. Stage IIIA shows lunate flattening and collapse but preserved carpal alignment. Stage IIIB adds scaphoid rotation and carpal instability to lunate collapse. Stage IV represents end-stage disease with carpal arthrosis. In stages I and II, conservative care predominates — splinting, load reduction, and pain management. From stage III onward, if pain and functional impairment progress, surgical options such as radial shortening osteotomy for ulnar-minus cases, lunate excision with prosthetic replacement, or partial wrist arthrodesis are considered. Coordination with a hand-surgery specialist is essential here, and regenerative approaches such as stem cell culture supernatant wrist injection should be positioned honestly as adjunctive support. For public information on joint disorders, please also refer to the Japanese Orthopaedic Association guidelines and resources.

Stem Cell Culture Supernatant Wrist Injection Does Not Address the Necrosis Itself — It Addresses the Intra-articular Inflammatory Environment

This is the point we most want to convey honestly. The central battle in Kienböck’s disease is restoring blood supply to and structural support for the necrotic lunate, and that is essentially the domain of surgical intervention and orthotic care. A stem cell culture supernatant wrist injection will not directly rebuild a collapsed bone. That said, as lunate osteonecrosis becomes chronic, synovitis in the wrist joint, increased load on surrounding cartilage, and secondary joint-space narrowing all contribute to symptom amplification as an intra-articular inflammatory environment. Growth factors contained in stem cell culture supernatant — such as TGF-β, IGF-1, and HGF — along with anti-inflammatory cytokines are thought to act on that synovitis and cartilage metabolic environment. Practically, this places stem cell culture supernatant wrist injection alongside splinting, occupational therapy, and lifestyle adjustment, most reasonably during the painful phase of stages I to II, during the waiting period before surgery, or against residual intra-articular inflammation after surgery. Rather than the overreaching hope that “an injection will bring the bone back,” what matters is sharing a modest role in medical terms with the patient: “softening the inflammatory axis so that other treatments can do their work without interference.” For details on our joint injection program using stem cell culture supernatant, please see this page.

Treatment Design: Combining Conservative Care, Injection, Splinting, and Surgery

Treatment design for lunate osteonecrosis is best thought of in three layers: conservative + adjunctive + surgical. The pillars of conservative care are wrist immobilization (a wrist support or cock-up splint), reduction of occupational load, appropriate use of anti-inflammatory analgesics, and, when needed, activity guidance from an occupational therapist. On top of this, stem cell culture supernatant wrist injection may be added at intervals of a few weeks to a few months to keep intra-articular inflammation on a gentler baseline. From stage III onward, however, if pain, carpal instability, or grip loss progress, delaying surgery may worsen functional prognosis. Collaboration with a hand-surgery specialist is decisive at this juncture, and continuing injections must not become an excuse to postpone the surgical decision. Stem cell culture supernatant wrist injection functions best as a quiet supporting player behind other therapies, and it is in that role that it can help sustain a long clinical course. Related columns on joint injections and wrist disorders are collected in the regenerative medicine column archive.

Frequently Asked Questions

Q. What early signs of lunate osteonecrosis should I watch for?

A heavy, dull ache at the center of the wrist that lasts more than a few weeks, tenderness on pressure near Lister’s tubercle, discomfort on forced dorsiflexion, and a gradual decrease in grip strength are all warning signs. If pain persists for months without any clear injury history, please consider an early MRI evaluation.

Q. Can stem cell culture supernatant wrist injection restore the lunate to normal?

It cannot. Intervention on the necrosis itself belongs to the domain of revascularization, surgery, and orthotic care. Supernatant wrist injection is a supportive option that helps modulate intra-articular synovitis and the surrounding cartilage environment; it is honest to position it as symptom relief during the painful phase and as a foundation supporting other treatments. Individual variation exists and effects have limits.

Q. If I am diagnosed at Lichtman stage III, is surgery unavoidable?

Not uniformly. Cases at stage IIIA with relatively mild pain and functional impairment may be observed under splinting and conservative pain management. However, once stage IIIB brings clear carpal instability, delayed surgery may accelerate progression to arthrosis, so consultation with a hand-surgery specialist becomes essential.

Q. How often should I receive stem cell culture supernatant wrist injections?

It depends on disease stage, age, and daily activity, but as a rough guide, injections are introduced every few weeks to a month during the painful phase, then transitioned to a maintenance schedule every few months once symptoms settle. Response is evaluated objectively via pain scores, grip strength, range of motion, and impact on daily activities; if response is limited, we consider extending intervals or moving to surgical evaluation.

──────────────

Supervising Physician: Shin Moriwaki, MD

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate

──────────────

📍AVAN TOKYO 銀座 関節再生医療

AVAN TOKYO Ginza Joint Regenerative Medicine

English / 中文 / Tiếng Việt available

Inquiries welcome via DM / LINE / Website / Phone.